<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displayed in a Venn diagram. (<b>B</b>) The −log10 of the <i>SAPS<sub>q-value</sub></i> is plotted on the y-axis and the <i>SAPS<sub>score</sub></i> along the x axis for each of the 5320 gene sets in the Molecular Signatures Database for their prognostic significance in the ER+/HER2− breast cancer molecular subtype. Each point in the scatterplot represents a gene set, and gene sets that achieved a <i>SAPS<sub>q-value</sub></i>≤0.05 and an absolute value (<i>SAPS<sub>score</sub></i>)≥1.3 are colored in red.</p
Results are presented as in Figure 2. Proliferation set. Genomic grade index. ER-associated genes (p...
<p>Breast cancer and ovarian cancer molecular subtypes were clustered with the 1300 gene sets with a...
Running enrichment scores (RESs) and the location of each probe set within the complete rank-ordered...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
A major goal in translational cancer research is to identify biological signatures driving cancer pr...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
<p>Venn diagrams showing the intersection of significant genes differentially downregulated (A) and ...
Background: First-generation gene signatures that identify breast cancer patients at risk of recurre...
Results are presented as in Figure 2. Proliferation set. Genomic grade index. ER-associated genes (p...
<p>Breast cancer and ovarian cancer molecular subtypes were clustered with the 1300 gene sets with a...
Running enrichment scores (RESs) and the location of each probe set within the complete rank-ordered...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>(<b>A</b>) The gene sets significant by at least one of the P values at the 0.05 level are displa...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
A major goal in translational cancer research is to identify biological signatures driving cancer pr...
<p>Gene sets in the analysis come from the Broad institute's MSigDB. These gene sets can be further ...
<p>Venn diagrams showing the intersection of significant genes differentially downregulated (A) and ...
Background: First-generation gene signatures that identify breast cancer patients at risk of recurre...
Results are presented as in Figure 2. Proliferation set. Genomic grade index. ER-associated genes (p...
<p>Breast cancer and ovarian cancer molecular subtypes were clustered with the 1300 gene sets with a...
Running enrichment scores (RESs) and the location of each probe set within the complete rank-ordered...